Acuren
Yahoo Finance • 20 days ago
Acuren Corporation (TIC): A Bull Case Theory
We came across a bullish thesis on Acuren Corporation on Kairos Research’s Substack. In this article, we will summarize the bulls’ thesis on TIC. Acuren Corporation's share was trading at $11.27 as of August 29th. TIC’s trailing and forwar... Full story
Yahoo Finance • 28 days ago
Five Below upgraded, Bill downgraded: Wall Street's top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top Upgrades: Telsey Advisory upgraded Five Below(FIVE... Full story
Yahoo Finance • last month
Acuren GAAP EPS of $0.00
* Acuren press release [https://seekingalpha.com/pr/20200713-acuren-corporation-reports-results-for-the-second-quarter-2025] (NYSE:TIC [https://seekingalpha.com/symbol/TIC]): Q2 GAAP EPS of $0.00. * Delivered revenue of $313.9 million... Full story
Yahoo Finance • 2 months ago
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: iTeos Therapeutics, Inc. (Nasdaq - ITOS), ZimVie Inc. (Nasdaq - ZIMV), PharmChem, Inc. (OTC - PCHM), NV5 Global, Inc. (Nasdaq - NVEE)
BALA CYNWYD, Pa., July 30, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ack... Full story
